论文部分内容阅读
目的 探讨尸体肾移植术后加速性排斥反应的临床治疗。方法 对7例临床上诊断为加速性排斥反应的患者给予强有力的抗排斥治疗。结果 自1996年5月至1999年5月所行的300例尸体肾移植患者中，7例发生加速性排斥反应，发生率2..33%，经强有力的抗排斥治疗后6例完全逆转，排斥逆转率85..5%，目前6例均健康存活，带肾存活率最长已达3年半；1例治疗无效切除移植肾。结论 加速性排斥反应的防治重点在于早期诊断、及时强有力的抗排斥治疗以及有针对性地防治抗排斥治疗过程中可能出现的各种并发症。
Objective To investigate the clinical treatment of accelerated rejection after cadaveric kidney transplantation. Methods Seven patients with clinically diagnosed accelerated rejection were given powerful anti-rejection therapy. Results Of the 300 cadaveric renal transplant patients who were performed between May 1996 and May 1999, 7 had an accelerated rejection rate of 2..33% and were completely reversed after vigorous anti-rejection therapy , The rejection rate was 85.5%. At present, all 6 cases survived well and the longest survival rate of renal allografts reached 3 years and a half. One case failed to remove the allograft kidneys. Conclusion The prevention and treatment of accelerated rejection mainly focus on early diagnosis, timely and powerful anti-rejection therapy and targeted prevention and treatment of various complications that may occur during anti-rejection therapy.